These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 22335920)

  • 1. The tumor microenvironment is a dominant force in multidrug resistance.
    Correia AL; Bissell MJ
    Drug Resist Updat; 2012; 15(1-2):39-49. PubMed ID: 22335920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
    Jena BC; Mandal M
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer drug resistance: A fleet to conquer.
    Hussain S; Singh A; Nazir SU; Tulsyan S; Khan A; Kumar R; Bashir N; Tanwar P; Mehrotra R
    J Cell Biochem; 2019 Sep; 120(9):14213-14225. PubMed ID: 31037763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes in cancer: Small transporters with big functions.
    Li X; Wang Y; Wang Q; Liu Y; Bao W; Wu S
    Cancer Lett; 2018 Oct; 435():55-65. PubMed ID: 30071288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Cancer-Associated Fibroblasts and Extracellular Vesicles in Tumorigenesis.
    Shoucair I; Weber Mello F; Jabalee J; Maleki S; Garnis C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1.
    Gillet JP; Gottesman MM
    Drug Resist Updat; 2012; 15(1-2):2-4. PubMed ID: 22465109
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy.
    Reggiani F; Gobbi G; Ciarrocchi A; Ambrosetti DC; Sancisi V
    Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188341. PubMed ID: 31931113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance.
    Parker AL; Teo WS; McCarroll JA; Kavallaris M
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28677634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-related networks: a help to understand, predict and change malignant transformation.
    Csermely P; Korcsmáros T
    Semin Cancer Biol; 2013 Aug; 23(4):209-12. PubMed ID: 23831276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC).
    Smith CIE
    Semin Cancer Biol; 2017 Aug; 45():36-49. PubMed ID: 27865897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A microRNA component of the neoplastic microenvironment: microregulators with far-reaching impact.
    Li X; Wu Z; Fu X; Han W
    Biomed Res Int; 2013; 2013():762183. PubMed ID: 23509776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloride channels in cancer: Focus on chloride intracellular channel 1 and 4 (CLIC1 AND CLIC4) proteins in tumor development and as novel therapeutic targets.
    Peretti M; Angelini M; Savalli N; Florio T; Yuspa SH; Mazzanti M
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2523-31. PubMed ID: 25546839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multi-factorial nature of clinical multidrug resistance in cancer.
    Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
    Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of microRNAs in remodeling the tumor microenvironment (Review).
    Pan Z; Tian Y; Niu G; Cao C
    Int J Oncol; 2020 Feb; 56(2):407-416. PubMed ID: 31894326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Microenvironment and Cell Fusion.
    Jiang E; Yan T; Xu Z; Shang Z
    Biomed Res Int; 2019; 2019():5013592. PubMed ID: 31380426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.